Form 4: Madrigal Pharmaceuticals Executive Waltermire Sells Shares

Robert E. Waltermire, a Senior VP at Madrigal Pharmaceuticals, sold shares of common stock on February 28, 2025.

Summary

• Robert E. Waltermire, a Senior VP at Madrigal Pharmaceuticals, sold 1,052 shares of common stock at a weighted average price of $340.9857 on February 28, 2025.
• He also sold 175 shares of common stock at a weighted average price of $341.5491 on the same day.
• Following these transactions, Waltermire directly owns 3,728 shares of Madrigal Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard disclosure of an executive selling shares, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical industry. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The sale of shares by a company executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.

Key Dates